APA (7th ed.) Citation

N, Z., L, C., E, L., KR, B., K, P., AS, C., . . . JA, S. (2024). Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease. Journal of pediatric gastroenterology and nutrition, 78(2), 261. https://doi.org/10.1002/jpn3.12074

Chicago Style (17th ed.) Citation

N, Zitomersky, Chi L, Liu E, Bray KR, Papamichael K, Cheifetz AS, Snapper SB, Bousvaros A, and Silvester JA. "Anti-infliximab Antibodies and Low Infliximab Levels Correlate with Drug Discontinuation in Pediatric Inflammatory Bowel Disease." Journal of Pediatric Gastroenterology and Nutrition 78, no. 2 (2024): 261. https://doi.org/10.1002/jpn3.12074.

MLA (9th ed.) Citation

N, Zitomersky, et al. "Anti-infliximab Antibodies and Low Infliximab Levels Correlate with Drug Discontinuation in Pediatric Inflammatory Bowel Disease." Journal of Pediatric Gastroenterology and Nutrition, vol. 78, no. 2, 2024, p. 261, https://doi.org/10.1002/jpn3.12074.